Luteolin

Category
flavonoid
Routes
Oral (PO)
Half-Life (t½)
PO: 3h
Formula
C15H10O6
Molecular Weight
286.24 g/mol
PubChem CID
5280445
Aliases
3',4',5,7-Tetrahydroxyflavone

Pharmacological Mechanism

Flavone with strong mast-cell-stabilising activity and microglial anti-inflammation (blocks IFN-γ-induced microglial activation). PDE4 inhibition contributes to anti-inflammatory profile. Attenuates oxidative stress via Nrf2 pathway.

Half-Life & Elimination Curve (PO: 3h)

100%50%25%12.5%0%0h0×t½3h1×t½6h2×t½9h3×t½12h4×t½15h5×t½0×t½ (0h): 100% remaining (~0.17 mg/L)1×t½ (3h): 50% remaining (~85.1 µg/L)2×t½ (6h): 25% remaining (~42.6 µg/L)3×t½ (9h): 12.5% remaining (~21.3 µg/L)4×t½ (12h): 6.3% remaining (~10.6 µg/L)5×t½ (15h): 3.1% remaining (~5.32 µg/L)
Plasma (PO)t½ Decay (3h)
  • 0×t½0h100% (0.17 mg/L)
  • 1×t½3h50% (85.1 µg/L)
  • 2×t½6h25% (42.6 µg/L)
  • 3×t½9h12.5% (21.3 µg/L)
  • 4×t½12h6.3% (10.6 µg/L)
  • 5×t½15h3.1% (5.32 µg/L)
Elimination t½3h (PO)
Rate Constant (ke)0.231 h⁻¹
Time to Peak (Tmax)2.59h
Est. Peak (Cmax)0.17 mg/L
Clearance (CL)19.4 L/h
97% Washout (5×t½)15h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References